{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T06:21:13Z","timestamp":1794464473053,"version":"4.9.1"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,11,24]],"date-time":"2023-11-24T00:00:00Z","timestamp":1700784000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,11,24]],"date-time":"2023-11-24T00:00:00Z","timestamp":1700784000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82070800"],"award-info":[{"award-number":["82070800"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Major basic research project of Shandong Natural Science Foundation","award":["ZR2022ZD15"],"award-info":[{"award-number":["ZR2022ZD15"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Lipids Health Dis"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Metabolic dysfunction-associated fatty liver disease (MAFLD) is frequently linked to type 2 diabetes mellitus (T2DM), and both conditions exacerbate the progression of the other. However, there is currently no standardized treatment or drug for MAFLD. In this study, A MAFLD animal model through a high-fat diet (HFD) along with administration of streptozotocin (STZ), and palmitic acid (PA)-induced AML12 cells were treated by puerarin. The objective of this study was to assess the therapeutic effect of puerarin, a flavonoid substance that possesses various pharmacological properties, on MAFLD. The results showed that puerarin administration enhanced glucose tolerance and insulin sensitivity, while also mitigating liver dysfunction and hyperlipidemia in MAFLD mice. Moreover, puerarin attenuated oxidative stress levels and inflammation in the liver. Transmission electron microscopy and Western blot analysis indicated that puerarin inhibited ferroptosis in vivo. Further mechanistic investigations revealed that puerarin upregulated SIRT1 expression, increased nuclear factor erythroid 2-related factor 2 (Nrf2) protein levels, and facilitated translocation into the nucleus. The protective effect of puerarin on PA-induced AML12 cells was diminished by the utilization of EX-527 (a SIRT1 inhibitor) and Nrf2 siRNA. Overall, the results demonstrate that puerarin ameliorates MAFLD by suppressing ferroptosis and inflammation via the SIRT1\/Nrf2 signaling pathway. The results emphasize the possible medicinal application of puerarin for managing MAFLD.<\/jats:p>","DOI":"10.1186\/s12944-023-01969-y","type":"journal-article","created":{"date-parts":[[2023,11,24]],"date-time":"2023-11-24T04:02:29Z","timestamp":1700798549000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":77,"title":["Puerarin ameliorates metabolic dysfunction-associated fatty liver disease by inhibiting ferroptosis and inflammation"],"prefix":"10.1186","volume":"22","author":[{"given":"Mengmeng","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Longqing","family":"Xia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huiqing","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nan","family":"Zang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingwen","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Zou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liming","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoyue","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qin","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jidong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fuqiang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kai","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,11,24]]},"reference":[{"issue":"1","key":"1969_CR1","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.jhep.2018.09.014","volume":"70","author":"SK Asrani","year":"2019","unstructured":"Asrani SK, Devarbhavi H, Eaton J, Kamath PS. Burden of Liver Diseases in the world. J Hepatol. 2019;70(1):151\u201371. https:\/\/doi.org\/10.1016\/j.jhep.2018.09.014","journal-title":"J Hepatol"},{"issue":"1","key":"1969_CR2","doi-asserted-by":"publisher","first-page":"126","DOI":"10.3748\/wjg.v29.i1.126","volume":"29","author":"MS Jeeyavudeen","year":"2023","unstructured":"Jeeyavudeen MS, Khan SKA, Fouda S, Pappachan JM. Management of metabolic-associated fatty Liver Disease: the diabetology perspective. World J Gastroenterol. 2023;29(1):126\u201343. https:\/\/doi.org\/10.3748\/wjg.v29.i1.126","journal-title":"World J Gastroenterol"},{"issue":"1","key":"1969_CR3","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1002\/hep.27981","volume":"63","author":"EM Koehler","year":"2016","unstructured":"Koehler EM, Plompen EP, Schouten JN, Hansen BE, Darwish Murad S, Taimr P, et al. Presence of Diabetes Mellitus and steatosis is associated with liver stiffness in a general population: the Rotterdam study. Hepatology. 2016;63(1):138\u201347. https:\/\/doi.org\/10.1002\/hep.27981","journal-title":"Hepatology"},{"issue":"10","key":"1969_CR4","doi-asserted-by":"publisher","first-page":"1410","DOI":"10.1136\/gut.2010.213553","volume":"59","author":"M Stepanova","year":"2010","unstructured":"Stepanova M, Rafiq N, Younossi ZM. Components of metabolic syndrome are Independent predictors of mortality in patients with chronic Liver Disease: a population-based study. Gut. 2010;59(10):1410\u20135. https:\/\/doi.org\/10.1136\/gut.2010.213553","journal-title":"Gut"},{"key":"1969_CR5","doi-asserted-by":"publisher","unstructured":"Tarantino G, Crocetto F, Di Vito C, Creta M, Martino R, Pandolfo SD, et al. Association of NAFLD and Insulin Resistance with non metastatic Bladder Cancer patients: a cross-sectional retrospective study. J Clin Med. 2021;10(2). https:\/\/doi.org\/10.3390\/jcm10020346","DOI":"10.3390\/jcm10020346"},{"issue":"7","key":"1969_CR6","doi-asserted-by":"publisher","first-page":"1496","DOI":"10.1111\/liv.15163","volume":"42","author":"G Feng","year":"2022","unstructured":"Feng G, Byrne CD, Targher G, Wang F, Zheng MH. Ferroptosis and metabolic dysfunction-associated fatty Liver Disease: is there a link? Liver Int. 2022;42(7):1496\u2013502. https:\/\/doi.org\/10.1111\/liv.15163","journal-title":"Liver Int"},{"issue":"1","key":"1969_CR7","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1186\/s11658-021-00254-z","volume":"26","author":"J Zhao","year":"2021","unstructured":"Zhao J, Hu Y, Peng J. Targeting programmed cell death in metabolic dysfunction-associated fatty Liver Disease (MAFLD): a promising new therapy. Cell Mol Biol Lett. 2021;26(1):17. https:\/\/doi.org\/10.1186\/s11658-021-00254-z","journal-title":"Cell Mol Biol Lett"},{"key":"1969_CR8","doi-asserted-by":"publisher","unstructured":"Capelletti MM, Manceau H, Puy H. Peoc\u2019h, Ferroptosis in Liver Diseases: An Overview. Int J Mol Sci. 2020;21(14). https:\/\/doi.org\/10.3390\/ijms21144908","DOI":"10.3390\/ijms21144908"},{"key":"1969_CR9","doi-asserted-by":"publisher","first-page":"726486","DOI":"10.3389\/fonc.2021.726486","volume":"11","author":"X Li","year":"2021","unstructured":"Li X, Huang J, Chen J, Zhan Y, Zhang R, Lu E, et al. A Novel Prognostic signature based on ferroptosis-related genes predicts the prognosis of patients with advanced bladder Urothelial Carcinoma. Front Oncol. 2021;11:726486. https:\/\/doi.org\/10.3389\/fonc.2021.726486","journal-title":"Front Oncol"},{"key":"1969_CR10","doi-asserted-by":"publisher","first-page":"102413doi","DOI":"10.1016\/j.redox.2022.102413","volume":"55","author":"H Zhou","year":"2022","unstructured":"Zhou H, Zhou YL, Mao JA, Tang LF, Xu J, Wang ZX, et al. NCOA4-mediated ferritinophagy is involved in ionizing radiation-induced ferroptosis of intestinal epithelial cells. Redox Biol. 2022;55:102413https:\/\/doi.org\/10.1016\/j.redox.2022.102413","journal-title":"Redox Biol"},{"issue":"8","key":"1969_CR11","doi-asserted-by":"publisher","first-page":"1425","DOI":"10.1080\/15548627.2016.1187366","volume":"12","author":"W Hou","year":"2016","unstructured":"Hou W, Xie Y, Song X, Sun X, Lotze MT, Zeh HJ 3, et al. Autophagy Promotes Ferroptosis by Degradation of Ferritin Autophagy. 2016;12(8):1425\u20138. https:\/\/doi.org\/10.1080\/15548627.2016.1187366","journal-title":"Autophagy Promotes Ferroptosis by Degradation of Ferritin Autophagy"},{"issue":"10","key":"1969_CR12","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.2174\/1381612826666200130090703","volume":"26","author":"A Sachinidis","year":"2020","unstructured":"Sachinidis A, Doumas M, Imprialos K, Stavropoulos K, Katsimardou A, Athyros VG. Dysmetabolic Iron overload in metabolic syndrome. Curr Pharm Des. 2020;26(10):1019\u201324. https:\/\/doi.org\/10.2174\/1381612826666200130090703","journal-title":"Curr Pharm Des"},{"issue":"9","key":"1969_CR13","doi-asserted-by":"publisher","first-page":"1398","DOI":"10.1016\/j.bbagen.2019.06.010","volume":"1863","author":"T Nakamura","year":"2019","unstructured":"Nakamura T, Naguro I, Ichijo H. Iron homeostasis and iron-regulated ROS in cell death, senescence and human Diseases. Biochim Biophys Acta Gen Subj. 2019;1863(9):1398\u2013409. https:\/\/doi.org\/10.1016\/j.bbagen.2019.06.010","journal-title":"Biochim Biophys Acta Gen Subj"},{"issue":"34","key":"1969_CR14","doi-asserted-by":"publisher","first-page":"E4966","DOI":"10.1073\/pnas.1603244113","volume":"113","author":"WS Yang","year":"2016","unstructured":"Yang WS, Kim KJ, Gaschler MM, Patel M, Shchepinov MS, Stockwell BR. Peroxidation of polyunsaturated fatty acids by lipoxygenases drives ferroptosis. Proc Natl Acad Sci U S A. 2016;113(34):E4966\u201375. https:\/\/doi.org\/10.1073\/pnas.1603244113","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"4","key":"1969_CR15","doi-asserted-by":"publisher","first-page":"361","DOI":"10.5152\/tjg.2016.16106","volume":"27","author":"E K\u00f6ro\u011flu","year":"2016","unstructured":"K\u00f6ro\u011flu E, Canbakan B, Atay K, Hatemi \u0130, Tuncer M, Dobrucal\u0131 A, et al. Role of oxidative stress and insulin resistance in Disease severity of non-alcoholic fatty Liver Disease. Turk J Gastroenterol. 2016;27(4):361\u20136. https:\/\/doi.org\/10.5152\/tjg.2016.16106","journal-title":"Turk J Gastroenterol"},{"issue":"1","key":"1969_CR16","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/s0168-8278(02)00073-9","volume":"37","author":"S Seki","year":"2002","unstructured":"Seki S, Kitada T, Yamada T, Sakaguchi H, Nakatani K, Wakasa K. Situ detection of lipid peroxidation and oxidative DNA damage in non-alcoholic fatty Liver Diseases. J Hepatol. 2002;37(1):56\u201362. https:\/\/doi.org\/10.1016\/s0168-8278(02)00073-9","journal-title":"J Hepatol"},{"issue":"1","key":"1969_CR17","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1006\/taap.2000.9066","volume":"170","author":"B Junge","year":"2001","unstructured":"Junge B, Carrion Y, Bosco C, Galleano M, Puntarulo S, Tapia G, et al. Effects of iron overload and lindane intoxication in relation to oxidative stress, Kupffer cell function, and liver injury in the rat. Toxicol Appl Pharmacol. 2001;170(1):23\u20138. https:\/\/doi.org\/10.1006\/taap.2000.9066","journal-title":"Toxicol Appl Pharmacol"},{"issue":"6","key":"1969_CR18","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1182\/blood.2019002907","volume":"136","author":"Y Yu","year":"2020","unstructured":"Yu Y, Jiang L, Wang H, Shen Z, Cheng Q, Zhang P, et al. Hepatic transferrin plays a role in systemic iron homeostasis and liver ferroptosis. Blood. 2020;136(6):726\u201339. https:\/\/doi.org\/10.1182\/blood.2019002907","journal-title":"Blood"},{"issue":"2","key":"1969_CR19","doi-asserted-by":"publisher","first-page":"87","DOI":"10.14348\/molcells.2016.2318","volume":"39","author":"BL Tang","year":"2016","unstructured":"Tang BL. Sirt1 and the Mitochondria. Mol Cells. 2016;39(2):87\u201395. https:\/\/doi.org\/10.14348\/molcells.2016.2318","journal-title":"Mol Cells"},{"key":"1969_CR20","doi-asserted-by":"publisher","first-page":"831168","DOI":"10.3389\/fimmu.2022.831168","volume":"13","author":"Y Yang","year":"2022","unstructured":"Yang Y, Liu Y, Wang Y, Chao Y, Zhang J, Jia Y, et al. Regulation of SIRT1 and its roles in inflammation. Front Immunol. 2022;13:831168. https:\/\/doi.org\/10.3389\/fimmu.2022.831168","journal-title":"Front Immunol"},{"key":"1969_CR21","doi-asserted-by":"publisher","first-page":"101107","DOI":"10.1016\/j.redox.2019.101107","volume":"23","author":"M Dodson","year":"2019","unstructured":"Dodson M, Castro-Portuguez R, Zhang DD. NRF2 plays a critical role in mitigating lipid peroxidation and ferroptosis. Redox Biol. 2019;23:101107. https:\/\/doi.org\/10.1016\/j.redox.2019.101107","journal-title":"Redox Biol"},{"issue":"7","key":"1969_CR22","doi-asserted-by":"publisher","first-page":"961","DOI":"10.1002\/ptr.5083","volume":"28","author":"YX Zhou","year":"2014","unstructured":"Zhou YX, Zhang H, Peng C. Puerarin: a review of pharmacological effects. Phytother Res. 2014;28(7):961\u201375. https:\/\/doi.org\/10.1002\/ptr.5083","journal-title":"Phytother Res"},{"issue":"6","key":"1969_CR23","doi-asserted-by":"publisher","first-page":"996","DOI":"10.1002\/ptr.6034","volume":"32","author":"X Zeng","year":"2018","unstructured":"Zeng X, Feng Q, Zhao F, Sun C, Zhou T, Yang J, et al. Puerarin inhibits TRPM3\/miR-204 to promote MC3T3-E1 cells proliferation, differentiation and mineralization. Phytother Res. 2018;32(6):996\u20131003. https:\/\/doi.org\/10.1002\/ptr.6034","journal-title":"Phytother Res"},{"issue":"8","key":"1969_CR24","doi-asserted-by":"publisher","first-page":"1771","DOI":"10.1142\/S0192415X18500891","volume":"46","author":"X Chen","year":"2018","unstructured":"Chen X, Yu J, Shi J. Management of Diabetes Mellitus with Puerarin, a natural isoflavone from Pueraria lobata. Am J Chin Med. 2018;46(8):1771\u201389. https:\/\/doi.org\/10.1142\/S0192415X18500891","journal-title":"Am J Chin Med"},{"key":"1969_CR25","doi-asserted-by":"publisher","first-page":"109847","DOI":"10.1016\/j.biopha.2020.109847","volume":"124","author":"YD Jeon","year":"2020","unstructured":"Jeon YD, Lee JH, Lee YM, Kim DK. Puerarin inhibits inflammation and oxidative stress in dextran sulfate sodium-induced Colitis mice model. Biomed Pharmacother. 2020;124:109847. https:\/\/doi.org\/10.1016\/j.biopha.2020.109847","journal-title":"Biomed Pharmacother"},{"issue":"9","key":"1969_CR26","doi-asserted-by":"publisher","first-page":"3601","DOI":"10.1002\/ptr.7526","volume":"36","author":"TH Pham","year":"2022","unstructured":"Pham TH, Lee GH, Jin SW, Lee SY, Han EH, Kim ND, et al. Puerarin attenuates hepatic steatosis via G-protein-coupled estrogen receptor-mediated calcium and SIRT1 signaling pathways. Phytother Res. 2022;36(9):3601\u201318. https:\/\/doi.org\/10.1002\/ptr.7526","journal-title":"Phytother Res"},{"issue":"10","key":"1969_CR27","doi-asserted-by":"publisher","first-page":"105145","DOI":"10.1016\/j.isci.2022.105145","volume":"25","author":"N Zang","year":"2022","unstructured":"Zang N, Cui C, Guo X, Song J, Hu H, Yang M, et al. cGAS-STING activation contributes to podocyte injury in diabetic Kidney Disease. iScience. 2022;25(10):105145. https:\/\/doi.org\/10.1016\/j.isci.2022.105145","journal-title":"iScience"},{"issue":"6","key":"1969_CR28","doi-asserted-by":"publisher","first-page":"1219","DOI":"10.1261\/rna.1563609","volume":"15","author":"PT Lang","year":"2009","unstructured":"Lang PT, Brozell SR, Mukherjee S, Pettersen EF, Meng EC, Thomas V, et al. DOCK 6: combining techniques to model RNA-small molecule complexes. RNA. 2009;15(6):1219\u201330. https:\/\/doi.org\/10.1261\/rna.1563609","journal-title":"RNA"},{"issue":"11","key":"1969_CR29","doi-asserted-by":"publisher","first-page":"1986","DOI":"10.1021\/ci1001982","volume":"50","author":"S Mukherjee","year":"2010","unstructured":"Mukherjee S, Balius TE, Rizzo RC. Docking validation resources: protein family and ligand flexibility experiments. J Chem Inf Model. 2010;50(11):1986\u20132000. https:\/\/doi.org\/10.1021\/ci1001982","journal-title":"J Chem Inf Model"},{"key":"1969_CR30","doi-asserted-by":"publisher","first-page":"956688","DOI":"10.3389\/fimmu.2022.956688","volume":"13","author":"J Zhou","year":"2022","unstructured":"Zhou J, Zhang N, Aldhahrani A, Soliman MM, Zhang L, Zhou F. Puerarin ameliorates nonalcoholic fatty liver in rats by regulating hepatic lipid accumulation, oxidative stress, and inflammation. Front Immunol. 2022;13:956688. https:\/\/doi.org\/10.3389\/fimmu.2022.956688","journal-title":"Front Immunol"},{"key":"1969_CR31","doi-asserted-by":"publisher","unstructured":"Mancardi D, Mezzanotte M, Arrigo E, Barinotti A, Roetto A. Iron overload, oxidative stress, and ferroptosis in the failing heart and liver. Antioxid (Basel). 2021;10(12). https:\/\/doi.org\/10.3390\/antiox10121864","DOI":"10.3390\/antiox10121864"},{"key":"1969_CR32","doi-asserted-by":"publisher","unstructured":"Kajarabille N, Latunde-Dada GO. Programmed cell-death by Ferroptosis: antioxidants as Mitigators. Int J Mol Sci. 2019;20(19). https:\/\/doi.org\/10.3390\/ijms20194968","DOI":"10.3390\/ijms20194968"},{"issue":"9","key":"1969_CR33","doi-asserted-by":"publisher","first-page":"2054","DOI":"10.1080\/15548627.2020.1810918","volume":"17","author":"X Chen","year":"2021","unstructured":"Chen X, Li J, Kang R, Klionsky DJ, Tang D. Ferroptosis: machinery and regulation. Autophagy. 2021;17(9):2054\u201381. https:\/\/doi.org\/10.1080\/15548627.2020.1810918","journal-title":"Autophagy"},{"issue":"17","key":"1969_CR34","doi-asserted-by":"publisher","first-page":"1727","DOI":"10.1089\/ars.2017.7342","volume":"29","author":"C Tonelli","year":"2018","unstructured":"Tonelli C, Chio IIC, Tuveson DA. Transcriptional regulation by Nrf2. Antioxid Redox Signal. 2018;29(17):1727\u201345. https:\/\/doi.org\/10.1089\/ars.2017.7342","journal-title":"Antioxid Redox Signal"},{"issue":"7","key":"1969_CR35","doi-asserted-by":"publisher","first-page":"852","DOI":"10.7150\/ijbs.19370","volume":"13","author":"RB Ding","year":"2017","unstructured":"Ding RB, Bao J, Deng CX. Emerging roles of SIRT1 in fatty Liver Diseases. Int J Biol Sci. 2017;13(7):852\u201367. https:\/\/doi.org\/10.7150\/ijbs.19370","journal-title":"Int J Biol Sci"},{"issue":"7","key":"1969_CR36","doi-asserted-by":"publisher","first-page":"2181","DOI":"10.1007\/s11011-022-00956-z","volume":"37","author":"S Patel","year":"2022","unstructured":"Patel S, Khan H, Majumdar A. Crosstalk between Sirtuins and Nrf2: SIRT1 activators as emerging treatment for diabetic neuropathy. Metab Brain Dis. 2022;37(7):2181\u201395. https:\/\/doi.org\/10.1007\/s11011-022-00956-z","journal-title":"Metab Brain Dis"},{"issue":"4","key":"1969_CR37","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1016\/j.chembiol.2020.03.011","volume":"27","author":"A Anandhan","year":"2020","unstructured":"Anandhan A, Dodson M, Schmidlin CJ, Liu P, Zhang DD. Breakdown of an Ironclad Defense System: the critical role of NRF2 in mediating ferroptosis. Cell Chem Biol. 2020;27(4):436\u201347. https:\/\/doi.org\/10.1016\/j.chembiol.2020.03.011","journal-title":"Cell Chem Biol"}],"container-title":["Lipids in Health and Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12944-023-01969-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12944-023-01969-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12944-023-01969-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,24]],"date-time":"2023-11-24T04:04:57Z","timestamp":1700798697000},"score":1,"resource":{"primary":{"URL":"https:\/\/lipidworld.biomedcentral.com\/articles\/10.1186\/s12944-023-01969-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11,24]]},"references-count":37,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["1969"],"URL":"https:\/\/doi.org\/10.1186\/s12944-023-01969-y","relation":{},"ISSN":["1476-511X"],"issn-type":[{"value":"1476-511X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,11,24]]},"assertion":[{"value":"10 August 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 November 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 November 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All experiments and treatments on mice were in accordance with the International Guidelines for the Use of Laboratory Animals. The experimental animal protocols received the acceptance of the Ethics Committee of Shandong University (permission number: SYXK20190005).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"202"}}